{"product_id":"onco-nephrology-hardback-9780323549455","title":"Onco-Nephrology (Hardback) 9780323549455","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eOnco-Nephrology\u003c\/font\u003e\u003cbr\u003e\r\n\r\n\r\n\u003c\/p\u003e\n\u003cp\u003e\u003cem\u003e\u003cp\u003eDefinitive guidance at the intersection of nephrology and oncology\u003c\/p\u003e\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eKevin W. Finkel (Author), Mark Anthony Perazella (Author), Eric P Cohen (Author)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780323549455, Elsevier Health Sciences\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eHardback, published 22 August 2019\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e384 pages, 380 illustrations (270 in full color)\u003cbr\u003e27.6 x 21.5 x 2.6 cm, 1.34 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003e\u003cp\u003eKidney disease and cancer are frequent comorbidities that require specialized knowledge and expertise from both the nephrologist and the oncologist. Written by three pioneers in this growing subspecialty, \u003ci\u003eOnco-Nephrology\u003c\/i\u003e provides \u003cb\u003eauthoritative, definitive coverage of the mechanism and management of these two life-threatening diseases\u003c\/b\u003e. This unique, single-volume resource covers current protocols and recommends management therapies to arrest kidney failure and allow oncologic treatments to continue and succeed\u003ci\u003e.\u003c\/i\u003e\u003c\/p\u003e\n\u003cul\u003e \u003cli\u003eAddresses \u003cb\u003eacute and chronic kidney diseases that develop from a variety of cancers\u003c\/b\u003e. This includes direct kidney injury from the malignancy, paraneoplastic effects of the cancer, and various cancer agents used to treat the malignancy.\u003c\/li\u003e  \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eDiscusses \u003cb\u003ekey issues regarding kidney disease in patients with cancer\u003c\/b\u003e, including conventional chemotherapeutic regimens and new novel therapies (targeted agents and immunotherapies) or the malignancies themselves that may promote kidney injury; patients with chronic kidney disease who acquire cancer unrelated to renal failure; and kidney transplantation, which has been shown to carry an increased risk of cancer.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eContains \u003cb\u003ededicated chapters for each class of the conventional chemotherapeutic agents\u003c\/b\u003e, targeted cancer agents, and cancer immunotherapies including the basic science, pathogenic mechanisms of injury, clinical manifestations, and treatment.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eIncludes \u003cb\u003especial chapters\u003c\/b\u003e devoted to the individual classes of chemotherapies that relate to kidney disease for quick reference. Discusses \u003cb\u003eincreasingly complex problems\u003c\/b\u003e due to more numerous and specialized anti-cancer drugs, as well as increased survival rates for both cancer and renal failure requiring long-term patient care.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eCovers \u003cb\u003eanti-VEGF (antivascular endothelial growth factor) agents and cancer immunotherapies\u003c\/b\u003e – treatments that are being recognized for adverse kidney effects.\u003c\/li\u003e \u003cp\u003e \u003c\/p\u003e\n\u003cli\u003eUtilizes a clear, logical format \u003cb\u003ebased on the ASN Core Curriculum for Onco-Nephrology\u003c\/b\u003e, making this reference an excellent tool for board review, as well as a practical resource in daily practice.\u003c\/li\u003e \u003cb\u003e \u003cli\u003eEnhanced\u003c\/li\u003e\u003c\/b\u003e \u003cb\u003eeBook version included with purchase. \u003c\/b\u003eYour enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.\u003c\/ul\u003e\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSECTION 1\u003cbr\u003eFluid and Electrolyte Disorders in Cancer Patients\u003cbr\u003e1 Kidney Function\u003cbr\u003e2 Dysnatremias in Cancer\u003cbr\u003e3 Potassium Disorders\u003cbr\u003e4 Calcium and Phosphorus Disorders\u003cbr\u003e5 Volume Disorders and Fluid Resuscitation\u003cbr\u003eSECTION 2\u003cbr\u003eParaprotein-Related Kidney Diseases\u003cbr\u003e6 Paraproteins\u003cbr\u003e7 Cast Nephropathy\u003cbr\u003e8 Systemic Light Chain Amyloidosis\u003cbr\u003e9 Monoclonal Immunoglobulin Deposition Disease\u003cbr\u003e10 Fibrillary and Immunotactoid Glomerulonephritis\u003cbr\u003eSECTION 3\u003cbr\u003eHematopoietic Stem Cell Associated Kidney Disease\u003cbr\u003e11 Hematopoietic Cell Transplant Associated Kidney Injury\u003cbr\u003e12 Sinusoidal Obstruction Syndrome\u003cbr\u003e13 Thrombotic Microangiopathy\u003cbr\u003e14 Graft-Versus-Host Disease\u003cbr\u003e15 Chronic Kidney Disease, End-Stage Renal Disease, and Bone Marrow Transplant\u003cbr\u003eSECTION 4\u003cbr\u003eChemotherapy and Radiation Related Kidney Diseases\u003cbr\u003e16 Conventional Chemotherapy\u003cbr\u003e17 Targeted Cancer Therapies (Biologics)\u003cbr\u003e18 Adverse Kidney Effects of Immunotherapies\u003cbr\u003e19 Chemotherapy in Chronic Kidney Disease and Dialysis\u003cbr\u003e20 Radiation Nephropathy\u003cbr\u003eSECTION 5\u003cbr\u003eParaneoplastic Glomerulopathies\u003cbr\u003e21 Paraneoplastic Glomerular Diseases\u003cbr\u003e22 Paraneoplastic Glomerulonephritis\u003cbr\u003e23 Hematologic Malignancies\u003cbr\u003e24 Cancer Screening Recommendations\u003cbr\u003eSECTION 6\u003cbr\u003eRenal Tumors\u003cbr\u003e25 Renal Cell Cancer\u003cbr\u003e26 Wilms Tumor and von Hippel Lindau Disease\u003cbr\u003e27 Tuberous Sclerosis Complex and the Kidney\u003cbr\u003e28 Evaluation of a Renal Cyst\/Mass\u003cbr\u003eSECTION 7\u003cbr\u003eAcute Kidney Injury\u003cbr\u003e29 Acute Kidney Injury Incidence, Pathogenesis, and Outcomes\u003cbr\u003e30 Tumor Lysis Syndrome\u003cbr\u003e31 Obstructive Nephropathy in Cancer\u003cbr\u003e32 Renal Replacement Therapies\u003cbr\u003eSECTION 8\u003cbr\u003eChronic Kidney Disease and Cancer\u003cbr\u003e33 Chronic Kidney Disease as a Complication of Cancer, With Special Focus on Kidney and Urothelial Tumors\u003cbr\u003e34 Incidence of Cancer and Screening Recommendations\u003cbr\u003e35 Cancer in Renal Transplant Patients\u003cbr\u003eSECTION 9\u003cbr\u003eKidney Infections\u003cbr\u003e36 Renal Infections in Cancer Patients\u003cbr\u003eSECTION 10\u003cbr\u003eInfiltrative Diseases\u003cbr\u003e37 Kidney Disease in Leukemia\u003cbr\u003e38 Kidney Disease in Lymphoma\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Renal medicine \u0026amp; nephrology [\u003ca title=\"See our other books on Renal medicine \u0026amp; nephrology\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Renal%20medicine%20\u0026amp;%20nephrology%20%5BMJR%5D%22\"\u003eMJR\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Elsevier","offers":[{"title":"Default Title","offer_id":46648835637528,"sku":"9780323549455","price":116.99,"currency_code":"GBP","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780323549455_1c820ccd-f19f-4397-9e92-16bc5eb3e1f1.jpg?v=1694989940","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/onco-nephrology-hardback-9780323549455","provider":"Freshly Printed Books","version":"1.0","type":"link"}